HIGHLIGHTS
- who: Stefan Nagel and colleagues from the Department of Human and Animal Cell Lines, Leibniz-Institute DSMZ, Braunschweig, Germany have published the research: Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma, in the Journal: Biomedicines 2022, 10, 1608. of /2022/
- what: The authors focused on seven amplicons exhibiting at least a 10-fold rise in their copy numbers which were located at 6p25, 9p24, 9p13, 16p13, 16p12, 16p11 and 20q13 .
- how: These data indicated that these cell lines differ in HLX regulation via protein-acetylation. The data indicated that IRF4 inhibited . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.